[Systemic effects of beta-blockaders in eyedrops].
Tanneau
R
R
Jouquan
J
J
Pennec
Y L
YL
Le Menn
G
G
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D006994:Hypoaldosteronism / Q000139:chemically induced*; D009883:Ophthalmic Solutions / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D006493:Heparin
Effets systémiques des bêtabloqueurs en collyre.